CT imaging showing the congenital heart defect of left heart hypoplastic syndrome. Researchers at Ann & Robert H. Lurie Children’s Hospital think they found a way to treat the condition by returning the heart to a fetal state the heart to repair itself. Image courtesy of Renee Bullock-Palmer, MD
Gene manipulation can revert the cardiomyocytes back to a fetal state, allowing them to regenerate. Researchers are now looking for drugs to mimic the effect.
Three patient deaths, 31 injuries and 322 complaints led to an FDA Class 1 recall of Teleflex/Arrow International intra-aortic balloon pump catheter kits.
More than 5,600 cardiac ultrasound measurements are now automated using artificial intelligence in the new Siemens Acuson Origin echocardiography system. It is the first echo system to use AI to help automate workflows and and anticipate next actions to greatly speed efficiency and increase reproducibility between sonographers. Photo by Dave Fornell at ESC 2023
New cardiac ultrasound advances, from AI to completely study workflow, new 3D/4D catheters, virtual reality simulators, to robot-assisted ultrasound, will be presented on the expo floor of ASE 2024 this weekend in Portland.
The central illustration from a study that shows the impact of ECG AI algorithm study case and control selection to train artificial intelligence to better screen patients for cardiac amyloidosis. Image courtesy of JACC Advances.
Early detection of cardiac amyloidosis is leads to the best outcomes, but it is often missed until later stages. AI is being developed to help detect these patients earlier using ECG and echo.
The Improving Seniors’ Timely Access to Care Act has been considered by Congress multiple times, getting closer than ever in 2023. Will 2024 be the year it finally lands on the president's desk?
Early research suggests Kardium's PFA system could give cardiologists a new tool for the fight against atrial fibrillation. The company plans to study its technology even more with this latest round of funding.
Researchers explored data from 23 different studies, identifying a “positive and almost linear association” between alcohol consumption and hypertension.
While multiple studies have confirmed that TAVR and surgery are associated with comparable outcomes, it is important to take an individualized approach to all treatment decisions.
According to the FDA, a total of 10 people have been hospitalized due to symptoms associated with these products. They are marketed as a "leading form of microdosing."
